QUIAPEG PHARMACEUTICALS HOLDING AB

News QuiaPEG Pharmaceuticals Holding AB

Equities

QUIA

SE0020678159

End-of-day quote Nasdaq Stockholm Other stock markets 06:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
0.0738 ^SEK	+13.54%		+7.74%	+11.65%

Feb. 26	QuiaPEG Pharmaceuticals Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 15	QuiaPEG, Net Zero Infrastructure Nears Conclusion of Formal License Agreement	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

QuiaPEG Pharmaceuticals Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 26	CI
QuiaPEG has submitted a formal application to Nasdaq in relation to the company’s acquisition of intellectual property rights from Rosemonkey Ltd.	Feb. 21	AQ
QuiaPEG has submitted a formal application to Nasdaq for the reverse acquisition of Rosemonkey Ltd.	Feb. 20	AQ
QuiaPEG, Net Zero Infrastructure Nears Conclusion of Formal License Agreement	Feb. 15	MT
QuiaPEG och Net Zero Infrastucture take next step to a formal license agreement	Feb. 15	AQ
QuiaPeg Shares Gain on Nonbinding Deal with Net Zero Infrastructure	Jan. 18	MT
QuiaPeg Pharmaceuticals Shares Plunge Amid Reverse Takeover Deal With Rosemonkey	Nov. 08	MT
QuiaPEG enters conditional agreement on a reverse takeover and financing to enable continued business development of existing operations	Nov. 08	AQ
QuiaPEG Pharmaceuticals Holding AB Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
QUIA Stock
News QuiaPEG Pharmaceuticals Holding AB

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW